▶ 調査レポート

世界の店頭販売(OTC)鎮痛薬市場予測(~2028年):タブレット、カプセル、その他

• 英文タイトル:Global Over the Counter (OTC) Analgesics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の店頭販売(OTC)鎮痛薬市場予測(~2028年):タブレット、カプセル、その他 / Global Over the Counter (OTC) Analgesics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22E8919資料のイメージです。• レポートコード:GIR-22E8919
• 出版社/出版日:GlobalInfoResearch / 2022年5月
• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
店頭販売(OTC)鎮痛薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の店頭販売(OTC)鎮痛薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

店頭販売(OTC)鎮痛薬市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・タブレット、カプセル、その他

用途別セグメントは次のように区分されます。
・小売薬局、病院薬局、オンライン薬局

世界の店頭販売(OTC)鎮痛薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Johnson & Johnson、AstraZeneca、Novartis、Sun Pharma、Bayer AG、Boehringer Ingelheim International GmbH、GlaxoSmithKline PLC、Reckitt Benckiser Group PLC、Sanofi SA、Takeda Pharmaceutical Company Limited.

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、店頭販売(OTC)鎮痛薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な店頭販売(OTC)鎮痛薬メーカーの企業概要、2019年~2022年までの店頭販売(OTC)鎮痛薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な店頭販売(OTC)鎮痛薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別店頭販売(OTC)鎮痛薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの店頭販売(OTC)鎮痛薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での店頭販売(OTC)鎮痛薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および店頭販売(OTC)鎮痛薬の産業チェーンを掲載しています。
・第13、14、15章では、店頭販売(OTC)鎮痛薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Pfizer、Johnson & Johnson、AstraZeneca、Novartis、Sun Pharma、Bayer AG、Boehringer Ingelheim International GmbH、GlaxoSmithKline PLC、Reckitt Benckiser Group PLC、Sanofi SA、Takeda Pharmaceutical Company Limited.
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:タブレット、カプセル、その他
・用途別分析2017年-2028年:小売薬局、病院薬局、オンライン薬局
・店頭販売(OTC)鎮痛薬の北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・店頭販売(OTC)鎮痛薬のヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・店頭販売(OTC)鎮痛薬のアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・店頭販売(OTC)鎮痛薬の南米市場規模2017年-2028年:ブラジル、アルゼンチン
・店頭販売(OTC)鎮痛薬の中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Over the Counter (OTC) Analgesics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Over the Counter (OTC) Analgesics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Retail Pharmacies accounting for % of the Over the Counter (OTC) Analgesics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Over the Counter (OTC) Analgesics include Pfizer, Johnson & Johnson, AstraZeneca, Novartis, and Sun Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Over the Counter (OTC) Analgesics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Capsule
Other
Market segment by Application can be divided into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
The key market players for global Over the Counter (OTC) Analgesics market are listed below:
Pfizer
Johnson & Johnson
AstraZeneca
Novartis
Sun Pharma
Bayer AG
Boehringer Ingelheim International GmbH
GlaxoSmithKline PLC
Reckitt Benckiser Group PLC
Sanofi SA
Takeda Pharmaceutical Company Limited.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Over the Counter (OTC) Analgesics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Over the Counter (OTC) Analgesics, with price, sales, revenue and global market share of Over the Counter (OTC) Analgesics from 2019 to 2022.
Chapter 3, the Over the Counter (OTC) Analgesics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Over the Counter (OTC) Analgesics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Over the Counter (OTC) Analgesics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Over the Counter (OTC) Analgesics.
Chapter 13, 14, and 15, to describe Over the Counter (OTC) Analgesics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Over the Counter (OTC) Analgesics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Over the Counter (OTC) Analgesics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Over the Counter (OTC) Analgesics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Over the Counter (OTC) Analgesics Market Size & Forecast
1.4.1 Global Over the Counter (OTC) Analgesics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Over the Counter (OTC) Analgesics Sales in Volume (2017-2028)
1.4.3 Global Over the Counter (OTC) Analgesics Price (2017-2028)
1.5 Global Over the Counter (OTC) Analgesics Production Capacity Analysis
1.5.1 Global Over the Counter (OTC) Analgesics Total Production Capacity (2017-2028)
1.5.2 Global Over the Counter (OTC) Analgesics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Over the Counter (OTC) Analgesics Market Drivers
1.6.2 Over the Counter (OTC) Analgesics Market Restraints
1.6.3 Over the Counter (OTC) Analgesics Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Over the Counter (OTC) Analgesics Product and Services
2.1.4 Pfizer Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Over the Counter (OTC) Analgesics Product and Services
2.2.4 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Over the Counter (OTC) Analgesics Product and Services
2.3.4 AstraZeneca Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Over the Counter (OTC) Analgesics Product and Services
2.4.4 Novartis Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sun Pharma
2.5.1 Sun Pharma Details
2.5.2 Sun Pharma Major Business
2.5.3 Sun Pharma Over the Counter (OTC) Analgesics Product and Services
2.5.4 Sun Pharma Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business
2.6.3 Bayer AG Over the Counter (OTC) Analgesics Product and Services
2.6.4 Bayer AG Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Boehringer Ingelheim International GmbH
2.7.1 Boehringer Ingelheim International GmbH Details
2.7.2 Boehringer Ingelheim International GmbH Major Business
2.7.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product and Services
2.7.4 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GlaxoSmithKline PLC
2.8.1 GlaxoSmithKline PLC Details
2.8.2 GlaxoSmithKline PLC Major Business
2.8.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product and Services
2.8.4 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Reckitt Benckiser Group PLC
2.9.1 Reckitt Benckiser Group PLC Details
2.9.2 Reckitt Benckiser Group PLC Major Business
2.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product and Services
2.9.4 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sanofi SA
2.10.1 Sanofi SA Details
2.10.2 Sanofi SA Major Business
2.10.3 Sanofi SA Over the Counter (OTC) Analgesics Product and Services
2.10.4 Sanofi SA Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Takeda Pharmaceutical Company Limited.
2.11.1 Takeda Pharmaceutical Company Limited. Details
2.11.2 Takeda Pharmaceutical Company Limited. Major Business
2.11.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product and Services
2.11.4 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Over the Counter (OTC) Analgesics Breakdown Data by Manufacturer
3.1 Global Over the Counter (OTC) Analgesics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Over the Counter (OTC) Analgesics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Over the Counter (OTC) Analgesics
3.4 Market Concentration Rate
3.4.1 Top 3 Over the Counter (OTC) Analgesics Manufacturer Market Share in 2021
3.4.2 Top 6 Over the Counter (OTC) Analgesics Manufacturer Market Share in 2021
3.5 Global Over the Counter (OTC) Analgesics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Over the Counter (OTC) Analgesics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Over the Counter (OTC) Analgesics Market Size by Region
4.1.1 Global Over the Counter (OTC) Analgesics Sales in Volume by Region (2017-2028)
4.1.2 Global Over the Counter (OTC) Analgesics Revenue by Region (2017-2028)
4.2 North America Over the Counter (OTC) Analgesics Revenue (2017-2028)
4.3 Europe Over the Counter (OTC) Analgesics Revenue (2017-2028)
4.4 Asia-Pacific Over the Counter (OTC) Analgesics Revenue (2017-2028)
4.5 South America Over the Counter (OTC) Analgesics Revenue (2017-2028)
4.6 Middle East and Africa Over the Counter (OTC) Analgesics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Over the Counter (OTC) Analgesics Sales in Volume by Type (2017-2028)
5.2 Global Over the Counter (OTC) Analgesics Revenue by Type (2017-2028)
5.3 Global Over the Counter (OTC) Analgesics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Over the Counter (OTC) Analgesics Sales in Volume by Application (2017-2028)
6.2 Global Over the Counter (OTC) Analgesics Revenue by Application (2017-2028)
6.3 Global Over the Counter (OTC) Analgesics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Over the Counter (OTC) Analgesics Sales by Type (2017-2028)
7.2 North America Over the Counter (OTC) Analgesics Sales by Application (2017-2028)
7.3 North America Over the Counter (OTC) Analgesics Market Size by Country
7.3.1 North America Over the Counter (OTC) Analgesics Sales in Volume by Country (2017-2028)
7.3.2 North America Over the Counter (OTC) Analgesics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Over the Counter (OTC) Analgesics Sales by Type (2017-2028)
8.2 Europe Over the Counter (OTC) Analgesics Sales by Application (2017-2028)
8.3 Europe Over the Counter (OTC) Analgesics Market Size by Country
8.3.1 Europe Over the Counter (OTC) Analgesics Sales in Volume by Country (2017-2028)
8.3.2 Europe Over the Counter (OTC) Analgesics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Over the Counter (OTC) Analgesics Sales by Type (2017-2028)
9.2 Asia-Pacific Over the Counter (OTC) Analgesics Sales by Application (2017-2028)
9.3 Asia-Pacific Over the Counter (OTC) Analgesics Market Size by Region
9.3.1 Asia-Pacific Over the Counter (OTC) Analgesics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Over the Counter (OTC) Analgesics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Over the Counter (OTC) Analgesics Sales by Type (2017-2028)
10.2 South America Over the Counter (OTC) Analgesics Sales by Application (2017-2028)
10.3 South America Over the Counter (OTC) Analgesics Market Size by Country
10.3.1 South America Over the Counter (OTC) Analgesics Sales in Volume by Country (2017-2028)
10.3.2 South America Over the Counter (OTC) Analgesics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Over the Counter (OTC) Analgesics Sales by Type (2017-2028)
11.2 Middle East & Africa Over the Counter (OTC) Analgesics Sales by Application (2017-2028)
11.3 Middle East & Africa Over the Counter (OTC) Analgesics Market Size by Country
11.3.1 Middle East & Africa Over the Counter (OTC) Analgesics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Over the Counter (OTC) Analgesics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Over the Counter (OTC) Analgesics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Over the Counter (OTC) Analgesics
12.3 Over the Counter (OTC) Analgesics Production Process
12.4 Over the Counter (OTC) Analgesics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Over the Counter (OTC) Analgesics Typical Distributors
13.3 Over the Counter (OTC) Analgesics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer